At Adamed Group, we have created, and continue to develop, a dossier of generic products which we license out to outside entities for a fee and make the dossier available to other organizations to fulfil their internal needs.

Our Licensing-out team is made up of experienced professionals responsible for selling Adamed Group FDF products in the global market.


The team’s extensive licensing-out experience allows us to offer the best partnership opportunities based on the ‘license-out’ model and the ‘win-win’ strategy.



Adamed Group conforms to even the most stringent EU standards; therefore:  our products are currently available in 70 markets across the world, including: Europe, Australia, New Zealand, South America, Africa, Asia and the Middle East where the brand is highly valued and recognized.

We provide full support in the areas of drug registration, intellectual property, marketing of new products and are willing openly to cooperate in order to successfully introduce new products, in the market with minimal risk and competitive pricing.

We operate foreign branches in Spain, Russia, Ukraine and Kazakhstan.


We provide our business partners with registration documents for FDF drugs formatted in accordance with CTD and conforming to even the most stringent regulations of the GMP and drug registration agencies of specific countries.


Our product line includes drugs based on our own or externally-prepared APIs.



  • Imatinib mesylate 100mg, 400mg capsules  

  • Sunitinib 12,5mg, 25mg, 50mg capsules




  • Amlodipine besylate 5mg, 10mg tablets

  • Amlodipine besylate 5mg, 10mg orodispersible tablets

  • Candesartan + Amlodipine Besylate 8mg/5mg, 8mg/10mg, 16mg/5mg, 16mg/10mg capsules

  • Candesartan + Amlodipine Besylate + HCTZ 16mg/5mg/12,5mg, 16mg/10mg/12,5mg, 32mg/5mg/25mg, 32mg/10mg/25mg tablets 

  • Cilostazol 50mg, 100mg tablets

  • Clopidogrel Bisulfate 75mg tablets

  • Eplerenon 25mg, 50mg tablets

  • Ezetimibe 10mg tablets

  • Ezetimibe + Rosuvastatin Calcium 10mg/5mg, 10mg/10mg, 10mg/20mg tablets

  • Perindopril + Amlodipine Besylate 4mg/5mg, 4mg/10mg, 8mg/5mg, 8mg/10mg tablets

  • Ramipril + Amlodipine Besylate 2,5mg/5mg, 5mg/5mg, 5mg/10mg, 10mg/5mg, 10mg/10mg capsules

  • Ramipril + Amlodipine Besylate + HCTZ 5mg/5mg/25mg, 5mg/10mg/25mg, 10mg/5mg/25mg, 5mg/5mg/12,5mg, 10mg/10mg/25mg, 2,5mg/5mg/12,5mg capsules

  • Rivaroxaban 10mg, 15mg, 20mg coated tablets 

  • Rosuvastatin Calcium 5mg, 10mg, 15mg, 20mg, 30mg, 40mg tablets

  • Rosuvastatin Calcium + Amlodipine Besylate 10mg/5mg, 10mg/10mg, 20mg/5mg, 20mg/10mg capsules

  • Rosuvastatin Calcium + ASA 5mg/100mg, 10mg/100mg, 20mg/100mg capsules



  • Progesterone 50mg, 100mg, 200mg vaginal tablets






  • Risedronate Sodium 35mg, 75mg film-coated tablets






  • Duloxetine 30mg, 60mg enteric-coated tablets

  • Fingolimod 0,5mg capsules 

  • Mianserin Hydrochloride 60mg coated tablets 

  • Olanzapine 5mg, 10mg tablets

  • Olanzapine 5mg, 10mg, 15mg, 20mg orodispersible tablets

  • Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg capsules

  • Zaleplon 5mg, 10mg capsules



  • Levocetirizine dihydrochloride 5mg film-coated tablets

  • Levocetirizine dihydrochloride 0,5mg/ml oral solution

  • Montelukast sodium 4mg, 5mg chewable tablets

  • Montelukast sodium 10mg film-coated tablets



  • Naproxen EC 250mg, 500mg enteric-coated tablets






  • Azithromycin 250mg, 500mg enteric-coated tablets








  • Acyclovir 200mg tablets

  • Cytisine 1,5mg coated tablets

  • Drotaverine + Metamizole + Caffeine 40mg/400mg/60mg tablets  

  • Furazidin 50mg 100mg tablets

  • Methamizole 500mg tablets

  • Naproxen 220mg tablets

  • Octenidine Dihydrochloride/Phenoxyethanol 1/20mg cutaneous liquid

  • Paracetamolum + Propyfenazone + Caffeine 250mg+150mg+50mg tablets

  • Simenthicone 240mg capsules





Sebastian Gromek
Director Licensing - Out & Commercial Alliances Management







Sylwia Berdzik - Kalarus
Strategic Marketing and Business Development Director Adamed Group